Carregant...
Dose Titration of Recombinant Factor VIIa Using Thromboelastograph Monitoring in a Child With Hemophilia and High Titer Inhibitors to Factor VIII: A Case Report and Brief Review
The administration of recombinant factor VIIa (rFVIIa) is complicated by a wide inter-subject variation in response, a short half-life, evolving indications for use, and the absence of a test that has been shown to correlate with clinical effect. This report describes a method used to titrate rFVIIa...
Guardat en:
| Publicat a: | J Extra Corpor Technol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of ExtraCorporeal Technology
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4680818/ https://ncbi.nlm.nih.gov/pubmed/17089513 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|